Pricing

Source-linked biotech diligence,
with the evidence trail attached.

ORION organizes returned clinical-trial records, curated FDA catalysts, market context, and disclosed research heuristics into a reviewable workspace. Choose the depth that matches your workflow.

Monthly billing only. Annual plans are not offered until annual checkout prices are configured and verified.

⚠ ORION's prediction sample is still small — results on the public Accuracy page are currently below the threshold we consider statistically meaningful, and we say so there rather than hiding it. We'd rather you see the real, current sample size before you subscribe than after.

Not ready to subscribe? Run one real analysis free — no card required.

Phase 0 · Starter

Professional

For independent analysts and small biotech teams reviewing source-linked diligence briefs.
$29 / mo
Monthly billing
Create account · checkout pending
  • 30 evidence dossiers / month
  • Entity Passport and claim-level sources
  • Watchlist change tracking
  • Competitive evidence table
  • PDF export; Excel export where a saved report is available
  • Single user
Important: checkout remains pending provider verification. Account creation does not imply payment was completed.
Use this plan for repeatable single-user diligence and exports.
Phase I · Solo

Research Desk · Solo Beta

For independent analysts running deep due diligence on every position.
$149 / mo
Monthly billing · Founding Beta price maintained for 12 months after activation
Create account · checkout pending
  • 200 evidence dossiers / month
  • Full Evidence Dossier and source appendix
  • Report generation history and comparisons
  • Competitive asset comparison
  • Experimental scores shown separately from facts
  • Review-ready PDF and Excel outputs
  • Single user
Not included: shared workspace, guaranteed external alert delivery, or multi-seat administration.
Email digest and Slack delivery are coming only after delivery verification.
REQUEST ACCESS
Phase II · Desk

Research Desk

For research teams evaluating portfolio monitoring and source-linked workflows with at least three users.
₩740,000 / seat / mo · 3-seat minimum
Request access · no self-serve checkout
Request access
The existing backend fund entitlement maps to Research Desk. Organization administration remains PILOT ONLY; API access is included only when explicitly provisioned.
  • Everything in Analyst, plus:
  • Portfolio Intelligence and Watchtower
  • Advanced Alerts and competitor pipeline comparison
  • CSV export (PILOT ONLY; provisioned scope)
  • API access where explicitly provisioned
  • Priority support
Pilot-only today: organization administration and monthly research review (available by arrangement). No SLA, SSO/SAML, or guaranteed continuous monitoring.
For a 6–8 week guided evaluation instead, request a Fund Pilot with named companies and written success criteria.
Phase III · Firm

Enterprise

For organizations that want to discuss a future production scope after pilot validation.
Inquiry inquiry only
No public SLA, SSO/SAML, or seat entitlement is offered today
Talk to us
  • Readiness and security review
  • Proposed coverage and data-boundary review
  • Commercial and operational terms confirmed before any commitment

Capability status

Paid promises are separated into what is live now and what remains pilot-only.

* Standard coverage. Large-cap companies with unusually broad clinical pipelines can take longer while ORION processes the additional source material.

Questions, answered straight

Is this investment advice?

No. ORION is a research tool. It surfaces, structures, and summarizes public clinical and regulatory data so you can form your own view. It does not make trades or give personalized recommendations.

Where does the data come from?

Public clinical-trial registries, FDA calendars, and company disclosures. Every generated claim links back to its source so you can verify before you act.

Can I cancel anytime?

Monthly self-serve plans cancel at the end of the current billing cycle. Annual billing is not currently offered. Guided-pilot terms, if any, are confirmed separately in writing.

Do you offer a trial?

The Free plan is the trial — one production analysis request a day, no card required, using the same source-connected workflow and scoring method as paid self-serve tiers. Source availability can vary and missing inputs remain unavailable. We don't currently offer a time-limited trial of paid tiers; reach out if you want a guided walkthrough on a name you care about first.

Is there a methodology document for compliance review?

Yes — every score's formula, weights, data sources, and disclosed limitations (including a published negative backtest result) are in the Methodology Whitepaper, downloadable as a PDF for institutional due diligence.

What does a Full-Access report actually look like?

See a full worked example — Watchtower monitoring results and Thesis Ledger history — on the sample report page. It's built from ORION's own illustrative demo company and clearly watermarked as a sample, not a real account's output.